Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:57 AM
Study NCT ID:
NCT04991805
Status:
COMPLETED
Last Update Posted:
2025-04-25
First Post:
2021-07-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-28
First Submit QC Date:
None
Study First Post Date:
2021-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-23
Last Update Post Date:
2025-04-25
Last Update Post Date Type:
ACTUAL